|Podcasts|July 8, 2022
Addressing Rising Rx Costs
Author(s)Nicholas Saraceno, Senior Editor, Julian Upton
How did the industry get here and what alternatives can be sought out?
Advertisement
Nelly Rose, PharmD, VP of clinical consulting for NFP, an insurance broker and consultant that provides solutions to clients that span numerous industries, addresses the increase in prescription drug spending, along with ways to find more affordable options for driving down pharmacy spend, including the impact of biosimilars in the marketplace.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
BoomRx Expands Access to Oral Semaglutide and Tirzepatide Using Nanoemulsion Delivery
2
The Hidden Economics of Health Insurance Affordability
3
Pharma Pulse: Novartis Warns of Trade Fragmentation; Hospital M&A Hits Record Low; Copay Shock Warning
4
Evaluate’s 2026 Pharma Forecast Signals Cautious Recovery, Rising M&A, and GLP-1 Market Shifts
5